Oxeltis is a medchem services company with hit to lead optimization services in various therapeutic fields. Oxeltis’ scientific team has a recognized expertise in specific areas of organic synthesis: heterocycles, macrocycles, nucleosides/nucleotides, phosphoramidites, modified sugars, oligo/polysaccharides, and PROTAC. Oxeltis has completed over 35 projects and several drug candidates delivered to its customers are in clinical development. Oxeltis works in EU, Japan, and North America.